Colorado reports that the transmission source has not yet been identified.
This article was first published by our sister brand Contagion®Live.com.
Public health officials in Pueblo County, Colorado, announced that a human case of the plague had been confirmed. The Pueblo Department of Public Health and Environment (PDPHE) is working with the Colorado Department of Public Health and Environment to investigate the case, according to a news statement.1
No specific information was provided about the person who contracted the disease or its type of plague—bubonic, septicemic, or pneumonic.1
“We advise all individuals to protect themselves and their pets from plague," stated Alicia Solis, program manager of the Office of Communicable Disease and Emergency Preparedness at PDPHE, in a news release.1
The plague bacterium (Yersinia pestis) is transmitted by fleas and cycles naturally among wild rodents. Plague occurs naturally in the western US where it circulates among wild rodents and other animals.2 It can infect humans and their pets.2 People get plague from bites of infected fleas by touching or skinning infected animals or inhaling droplets from the cough of an infected person or animal.1
Plague Geographics, Incidence Rates, and Other Cases This Year
The CDC estimates an average of 7 cases of plague are reported annually in the US, and over 80% of cases have been bubonic.3
The federal agency also reports most human cases in the US are acquired in 2 geographic regions:
Earlier this year, public health officials in 2 states reported individual plague cases. In February, Oregon public health officials announced that a resident had contracted bubonic plague through cat-to-human transmission. The individual and close contacts have received medication, with health officials stating no broader community risk.4 And in March, it was reported a New Mexico man died from the bubonic plague.5
These are all separate, individual cases with no connection between the cases.
What You Need to Know
Public health officials in Pueblo County, Colorado, have confirmed a human case of plague.
The plague bacterium (Yersinia pestis) is transmitted by fleas and cycles naturally among wild rodents. It occurs naturally in the western US and can infect humans and their pets through flea bites, contact with infected animals, or inhaling droplets from an infected person or animal.
Preventative measures include avoiding contact with sick or dead rodents, preventing pets from hunting, using flea control products, and cleaning areas where rodents might live.
Some preventative measures to avoid contracting bubonic plague include:
In terms of signs, CDC reports that the most common symptom is the “rapid development of a swollen and painful lymph gland called a bubo. A known flea bite or the presence of a bubo may help a doctor to consider plague as a cause of the illness,” the federal agency reports.5
People who live or have traveled to the western US or any places where the plague is endemic and are experiencing symptoms should seek medical care immediately, as the CDC writes on its site. The plague is diagnosed with a test and can be treated with antibiotics.5
“If you develop symptoms of plague, see a health care provider immediately. Plague can be treated successfully with antibiotics, but an infected person must be treated promptly to avoid serious complications or death,” Solis stated.1
Comprehensive Strategies in Wound Care: Insights From Madhavi Ponnapalli, MD
November 22nd 2024Madhavi Ponnapalli, MD, discusses effective wound care strategies, including debridement techniques, offloading modalities, appropriate dressing selection, compression therapy, and nutritional needs for optimal healing outcomes.
The Leapfrog Group and the Positive Effect on Hospital Hand Hygiene
November 21st 2024The Leapfrog Group enhances hospital safety by publicizing hand hygiene performance, improving patient safety outcomes, and significantly reducing health care-associated infections through transparent standards and monitoring initiatives.
Managing Multimorbidity and Polypharmacy in HIV: Insights From Michelle S. Cespedes, MD, MS
November 20th 2024Michelle S. Cespedes, MD, MS, discusses the challenges of managing multimorbidity and polypharmacy in HIV treatment, emphasizing patient education, evolving guidelines, and real-world insights from the REPRIEVE study.
Longhorn Vaccines and Diagnostics to Showcase Breakthrough Vaccine Data at IDWeek 2024
November 19th 2024Longhorn Vaccines and Diagnostics revealed promising data on universal influenza vaccine LHNVD-110 and AMR sepsis vaccine LHNVD-303 at IDWeek 2024, addressing critical global health challenges.